StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Vicapsys Life Sciences's operating income for the twelve months ending Sep 30, 2024 was -$1.11M. For fiscal 2023 it was -$1.05M.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.05M–
FY2022Dec 31, 2022-$984.79K–
FY2021Dec 31, 2021-$336.87K–
FY2020Dec 31, 2020-$765.84K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024-$198.86K–
Q2 FY2024Jun 30, 2024-$181.84K–
Q1 FY2024Mar 31, 2024-$204.26K–
Q4 FY2023Dec 31, 2023-$527.21K–
Q3 FY2023Sep 30, 2023-$175.42K–
Q2 FY2023Jun 30, 2023-$135.69K–
Q1 FY2023Mar 31, 2023-$211.28K–
Q4 FY2022Dec 31, 2022-$492.61K–
Q3 FY2022Sep 30, 2022-$145.08K–
Q2 FY2022Jun 30, 2022-$180.06K–
Q1 FY2022Mar 31, 2022-$167.05K–
Q4 FY2021Dec 31, 2021-$103.86K–
Q3 FY2021Sep 30, 2021-$111.18K–
Q2 FY2021Jun 30, 2021-$72.06K–
Q1 FY2021Mar 31, 2021-$49.77K–
Q4 FY2020Dec 31, 2020-$80.55K–
Q3 FY2020Sep 30, 2020-$89.22K–
Q2 FY2020Jun 30, 2020-$231.62K–
Q1 FY2020Mar 31, 2020-$364.46K–

More Vicapsys Life Sciences figures

See a number that looks wrong?